MD Anderson Cancer Center Thoracic-Head & Neck Med Onc
Welcome,         Profile    Billing    Logout  
 6 Trials 
5 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gillison, Maura
NCT05681039: Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Recruiting
2
29
US
Tiragolumab, Atezolizumab, MPDL3280A, TECENTRIQ, Standard of Care, Questionnaires, Cisplatin, Carboplatin
M.D. Anderson Cancer Center, Genentech, Inc.
Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma
11/24
11/26
KURRENT-HN, NCT04997902: Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Recruiting
1/2
40
US
Tipifarnib, Alpelisib, BYL719
Kura Oncology, Inc.
HNSCC
09/24
09/24
NCT05543629: A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

Active, not recruiting
1/2
225
Europe, US, RoW
BMS-986442, Nivolumab, Opdivo, BMS-936558, Docetaxel, Taxane / Toxotere chemotherapy, Carboplatin, Platinum chemotherapy, Pemexetred, Folate analog metabolic inhibitor, Paclitaxel, Taxane chemotherapy
Bristol-Myers Squibb
Advanced Solid Tumors, Non-small Cell Lung Cancer
07/24
07/24
SGNPDL1V-001, NCT05208762: A Study of SGN-PDL1V in Advanced Solid Tumors

Recruiting
1
322
Europe, Canada, US
SGN-PDL1V, pembrolizumab, Keytruda
Seagen Inc.
Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma, Ovarian Neoplasms, Melanoma, Triple Negative Breast Neoplasms, Gastric Cancer
07/25
12/26
Jia, Jessie
KURRENT-HN, NCT04997902: Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Recruiting
1/2
40
US
Tipifarnib, Alpelisib, BYL719
Kura Oncology, Inc.
HNSCC
09/24
09/24

Download Options